SCHEMBL14937962

SCHEMBL14937962

Cn1nccc1-c1ccc(C(F)(F)F)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP19A1 P11511 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
TRPV4 Q9HBA0 1/20 0.42
LRRK2 Q5S007 1/20 0.40
DRD1 P21728 1/20 0.40
METAP2 P50579 1/20 0.40
PDE10A Q9Y233 1/20 0.39
KCNH2 Q12809 5/20 0.38
PIK3CA P42336 3/20 0.38
PI4KB Q9UBF8 3/20 0.38
MAP4K4 O95819 1/20 0.38
MINK1 Q8N4C8 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
PIK3CD O00329 2/20 0.38
PIK3CB P42338 2/20 0.38
PI4KA P42356 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12269968 0.76 CYP1A2 (0.49) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL14938229 0.76 CYP1A2 (0.49) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL17796572 0.75 CYP1A2 (0.47) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL17654918 0.75 CYP1A2 (0.47) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL13680602 0.74 TRPV4 (0.42) TRPV4PDE10AKCNH2PIK3CAPI4KB
SCHEMBL19064527 0.74 HPGDS (0.50) TRPV4LRRK2PDE10AKCNH2PIK3CA
SCHEMBL17796454 0.73 POLB (0.46) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL14937594 0.72 CYP1A2 (0.64) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL14938025 0.72 TRPV4 (0.40) TRPV4PDE10AKCNH2PIK3CAPI4KB
SCHEMBL15047763 0.72 CYP1A2 (0.47) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642626-B2 Ethinyl-pyrazole derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-02-04 US disclosed
EP-2599775-A1 ETHINYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-05 EP disclosed
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE GABRE, GRIN3A, GRIK5 CYP1A2 835/4885CYP3A4 478/4885CYP2D6 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.